Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Impact of aerobic exercise capacity and procedure-related factors in lung cancer surgery

M. Licker, J-M. Schnyder, J-G. Frey, J. Diaper, V. Cartier, C. Inan, J. Robert, P-O. Bridevaux, J-M. Tschopp
European Respiratory Journal 2011 37: 1189-1198; DOI: 10.1183/09031936.00069910
M. Licker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: licker-marc-joseph@diogenes.hcuge.ch
J-M. Schnyder
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J-G. Frey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Diaper
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V. Cartier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Inan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Robert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P-O. Bridevaux
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J-M. Tschopp
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Over the past decades, major progress in patient selection, surgical techniques and anaesthetic management have largely contributed to improved outcome in lung cancer surgery. The purpose of this study was to identify predictors of post-operative cardiopulmonary morbidity in patients with a forced expiratory volume in 1 s <80% predicted, who underwent cardiopulmonary exercise testing (CPET).

In this observational study, 210 consecutive patients with lung cancer underwent CPET with completed data over a 9-yr period (2001–2009).

Cardiopulmonary complications occurred in 46 (22%) patients, including four (1.9%) deaths. On logistic regression analysis, peak oxygen uptake (peak V′O2) and anaesthesia duration were independent risk factors of both cardiovascular and pulmonary complications; age and the extent of lung resection were additional predictors of cardiovascular complications, whereas tidal volume during one-lung ventilation was a predictor of pulmonary complications. Compared with patients with peak V′O2 >17 mL·kg−1·min−1, those with a peak V′O2 <10 mL·kg−1·min−1 had a four-fold higher incidence of cardiac and pulmonary morbidity.

Our data support the use of pre-operative CPET and the application of an intra-operative protective ventilation strategy. Further studies should evaluate whether pre-operative physical training can improve post-operative outcome.

  • Cardiopulmonary exercise test
  • lung cancer
  • lung resection
  • peak oxygen consumption
  • post-operative morbidity

To date, lung resection is the only curative option for the early stages of lung cancer. Overall, perioperative mortality rates range between 2% and 5% and the incidence of post-operative cardiopulmonary complications varies between 20% and 40%, resulting in prolonged hospital stay and increased healthcare costs 1–3. Although up to 25% of patients may benefit from surgical resection, in the remaining patients, either the cancer stage is considered too advanced or comorbidities are judged too severe, precluding any benefit in terms of post-operative survival and quality of life 4.

Basically, selection criteria for lung resection entail a stepwise approach with distinct targets, first determining the resectability of the tumour, then assessing the severity of comorbidities and finally questioning the expected functional capacity following lung resection 5–7. Besides imaging techniques and lung functional investigations, cardiopulmonary exercise testing (CPET) has recently emerged as a noninvasive tool providing valuable diagnostic and prognostic information 8–10. During incremental physical workload, the physiological reserve of the heart, lungs and skeletal muscles can be quantified by monitoring ECG changes, heart rate and blood pressure responses, respiratory volumes, oxygen consumption and carbon dioxide production, as well as by grading dyspnoea and subjective feelings. Accordingly, interpretation of abnormal results during CPET is helpful for detecting significant coronary artery disease, ventricular or valvular dysfunction, gas exchange or ventilation abnormalities as well as skeletal muscle deconditioning 8, 11.

Several prospective studies have demonstrated that limitation of exercise capacity as expressed by peak oxygen uptake (peak V′O2) or maximal oxygen uptake was strongly predictive of perioperative mortality and cardiopulmonary morbidity 12–15. Based on these data, CPET has been endorsed by the European Respiratory Society (ERS) and the European Society of Thoracic Surgery (ESTS) and incorporated in a functional algorithm for the evaluation of candidates for lung resection 16, 17. These updated guidelines recommend that formal CPET should be performed in all surgical candidates with forced expiratory volume in 1 s (FEV1) or with diffusing capacity of the lung for carbon monoxide (DL,CO) <80% of predicted values. Interestingly, this algorithm dates back to the mid-1990s, being tested and subsequently validated in two cohorts of 80 and 135 patients 18, 19. Since this pioneering work, advances in surgical techniques and anaesthetic management have led to improved perioperative outcomes, despite increasing proportions of elderly and higher-risk patients 2, 20, 21.

In this study, we retrospectively analysed all lung resection candidates who underwent formal CPET according to the ERS/ESTS guidelines in our institution over the past decade. The main objective was to re-examine predictors of in-hospital cardiac and pulmonary morbidity based on patient comorbidity indices, various parameters of CPET and intra-operative procedure-related factors.

MATERIAL AND METHODS

Study design and settings

This was an observational cohort analysis performed on data prospectively collected in patients who underwent lung resection for lung cancer from January 2001 to December 2009 in a tertiary referral hospital (n = 243 patients). The study population included surgical candidates with FEV1 <80% pred who underwent CPET according to an algorithm initially proposed by Bolliger et al. 19 and updated in 2009 by a task force of the ERS/ESTS 16, 17. The study and the database were approved by the local institutional review board and informed consent was waived, given the retrospective analysis of existing documents and the anonymised database. All patients were operated on by a board-certified thoracic surgeon and were managed by the same team of cardiothoracic anaesthetists and chest physicians.

Patients and perioperative management

Besides clinical evaluation, ECG and laboratory screening, routine pre-operative work-up included pulmonary function tests (SensorMedics; Yonba Linda, CA, USA), lung biopsy, computed tomography (CT) scan and/or positron emission tomography of the chest and abdomen. Patients with abnormal spirometric results (FEV1 <80% pred), impaired exercise tolerance or cardiac risk factors, underwent complementary investigations, including CPET and DL,CO.

Symptom-limited CPET was performed on an upright electronically braked cycle ergometer (SensorMedics 2200 SP; SensorMedics). After a 2-min warm-up period at 20 W, an incremental protocol with 20 W·min−1 workload increases was started. The exercise test was stopped when the patients were exhausted, or at any ECG signs or clinical symptoms of myocardial ischaemia, including a fall in systolic blood pressure. Peak V′O2 was expressed in mL·min−1·kg−1 body weight and in mL·min−1·kg−1 predicted body weight (PBW) 22.

Before surgical incision, antimicrobial prophylaxis was administered (cefuroxime 1.5 g as a single dose). Lung resection with systematic lymph node sampling was performed through an anterolateral muscle-sparing thoracotomy while the contralateral lung was selectively ventilated with tidal volume (VT) ranging from 4 to 10 mL·kg−1 and with variable levels of positive end-expiratory pressure (PEEP; 0–10 cmH2O). Fast-track anaesthetic modalities entailed the administration of short-acting anaesthetic agents and low doses of intravenous opiates, provision of continuous thoracic epidural analgesia, monitoring neuromuscular blockade and goal-directed intravenous fluid loading. All patients were extubated in the operating theatre and were managed over the next 12–24 h in the post-anaesthesia recovery room before being transferred to the thoracic surgical unit. Post-operative management was standardised with particular emphasis on early feeding with close control of fluid balance, active mobilisation with lung recruitment manoeuvres and provision of multimodal analgesia, including nonsteroidal anti-inflammatory drugs, paracetamol and thoracic epidural blockade. Parenteral morphine was only administered to patients with contraindication for epidural puncture or non-functioning/displaced epidural catheter (10 (4.1%) out of 243 patients).

Data collection

The primary composite morbidity rate included operative mortality (death within 30 days of surgery or later if the patient was still hospitalised), as well as cardiovascular complications (myocardial infarction, arrhythmias, congestive heart failure, stroke, thromboembolism or renal dysfunction) and pulmonary complications (atelectasis, pneumonia or acute lung injury (ALI)) as detailed in the appendix and consistent with previous studies 2, 13.

Demographic, clinical, surgical and anaesthetic data, as well as pathological stage and perioperative complications, were recorded on a case report form for the index hospitalisation. Respiratory functional data included ergometric parameters (peak V’O2, workload, maximal ventilatory capacity and arterial oxygen pressure), baseline spirometric values and the predicted post-operative FEV1 (ppo FEV1) calculated by taking into account the number of open and functional segments removed 5. Intra-operatively, the following items were also recorded: VT during one-lung ventilation, amount of vasopressor drugs, urine output and fluid intake (colloids, crystalloids and blood products). All these data (94 items) were entered into a surgical database and cross-checked for accuracy.

Statistical analysis

Perioperative clinical, surgical and ergometric characteristics of patients with and without cardiovascular or respiratory complications (or both) were compared with the Chi-squared test for categorical variables (expressed in percentage) and the unpaired t-test (normal distribution) or Wilcoxon rank test (non-Gaussian distribution) for continuous variables (all expressed as mean±sd).

Variables that had a univariate probability value <0.20 or those judged to be clinically important were selected for inclusion in a logistic regression model. To avoid multi-colinearity, only one variable was retained in a set of variables with the highest correlation coefficient (>0.5). Independent predictors of cardiovascular and/or respiratory morbidity and factor-adjusted odds ratios with 95% confidence intervals were calculated. To further assess the reliability of the predictors, regression was repeated in 1,000 random bootstrap samples from the original dataset. Given the small number of perioperative deaths (only four cases), mortality was not separately analysed and these cases were included in morbidity analysis according to the type of complications. Model discrimination was evaluated by the area under the receiver operating characteristic (ROC) curve, and calibration was assessed with the Hosmer–Lemeshow goodness-of-fit statistic. All analysis were performed using SPSS software version 14.0 (SPSS, Chicago, IL, USA) and Stata software version 11.0 (Stata Corp, College Station, TX, USA). Statistical significance was specified to a two-tailed type I error (p-value) set below the 0.05 level.

RESULTS

A total of 210 patients with FEV1 <80% pred yielded completed datasets and were included in the study (fig. 1). Table 1 shows the baseline characteristics of patients stratified by peak V′O2. Patients with low peak V′O2 (<17 mL·kg−1·min−1) were more likely to be older, female and hypertensive; they also presented with a higher body mass index (BMI), higher American Society Association (ASA) risk classes, lower FEV1 (pre-operative and predicted post-operative values) and with earlier pathological stages. Rates of coronary artery disease, hypercholesterolaemia, diabetes mellitus, as well as smoking and alcohol status, did not differ significantly among the stratified peak V′O2 groups.

Figure 1–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1–

Flow chart of patients operated for lung cancer and stratified according to pre-operative peak oxygen uptake (V′O2) values. Post-operative morbidity data are expressed as n (%). FEV1: forced expiratory volume in 1 s; CPET: cardiopulmonary exercise testing.

View this table:
  • View inline
  • View popup
Table 1– Baseline characteristics stratified by peak oxygen uptake (V′O2)

Peak V′O2 expressed in mL·min−1·kg−1 PBW was higher than peak V′O2 expressed in mL·min−1·kg−1 absolute body weight (18.50±5.7 versus 16.0±5.3; p = 0.0003).

As described in table 2, 30-day mortality was 1.9% and all four deaths occurred in patients with peak V′O2 <17 mL·kg−1 and were primarily related to cardiovascular complications (n = 3) and ALI (n = 1). 46 patients experienced at least one cardiopulmonary complication (incidence of 22%). 36 pulmonary complications occurred in 28 patients (pneumonia, 18 cases; atelectasis, 15 cases; ALI, three cases). 30 cardiovascular complications occurred in 24 patients (arrhythmias, 17 cases; stroke, three cases; acute heart failure, six cases; myocardial infarction, two cases; pulmonary embolism, two cases). 16 patients presented with both cardiovascular and pulmonary complications. Overall, the incidence of complications did not differ in patients undergoing minor or major lung resection (19.2% versus 20.5%, respectively; p = 0.701).

View this table:
  • View inline
  • View popup
Table 2– Clinical and surgical characteristics of patients with and without complications

In univariate analysis, patients experiencing cardiopulmonary complications had lower pre-operative V′O2, they underwent longer and more extensive procedures and required larger doses of vasopressors at the time of surgery; in addition, a higher BMI was associated with a higher incidence of respiratory complications (table 3). In contrast, sex, smoking habits, alcohol consumption, the presence of coronary artery disease, hyperlipidaemia or diabetes mellitus did not differ between groups of patients with or without complications. After adjusting for other perioperative factors by logistic regression, peak V′O2 and anaesthesia duration remained independent predictors of cardiovascular and/or pulmonary complications; age and the extent of lung resection (pneumonectomy or bilobectomy) were additional predictors of cardiovascular complications whereas VT during one-lung ventilation was an independent risk factor of respiratory complications (table 4).

View this table:
  • View inline
  • View popup
Table 3– Characteristics of the four patients who died within the perioperative period
View this table:
  • View inline
  • View popup
Table 4– Results of logistic regression analysis for different dependent variables

As detailed in table 5, ROC curve analysis showed that the best cut-off values for peak V′O2 to predict cardiac complications were 13.6 mL·min−1·kg−1 and 16.2 mL·min−1·PBW−1 (c-indices, 0.71 versus 0.74, respectively; p = 0.445) whereas for pulmonary complications the best cut-off values were 12.8 mL·min−1·kg−1 and 15.8 mL·min−1·PBW−1 (c-indices, 0.72 versus 0.65, respectively; p = 0.304).

View this table:
  • View inline
  • View popup
Table 5– Areas under the receiver operating characteristic curves and cut-off values of various parameters for the prediction of cardiovascular and pulmonary complications

The incidence of cardiovascular and pulmonary complications increased in parallel with the reduction in peak V′O2 during exercise testing (fig. 2). Compared with patients with peak V′O2 >17 mL·kg−1·min−1, those with a peak V′O2 <10 mL·kg−1·min−1 had a four-fold higher incidence of cardiac and pulmonary morbidity.

Figure 2–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2–

Stratification of post-operative outcome according to peak oxygen uptake (V′O2) values expressed as mL·kg−1·min−1. Incidence of cardiac, pulmonary and total cardiopulmonary complications during the hospital stay following surgery.

DISCUSSION

In this retrospective analysis of surgical candidates with FEV1 <80%, we demonstrated that markers of pre-operative cardiopulmonary fitness and the duration of anaesthesia were the best predictors of cardiopulmonary complications following lung cancer surgery. In addition, age and the extent of lung resection were also considered independent risk factors of cardiovascular complications, whereas VT during one-lung ventilation was a predictor of pulmonary complications.

Among CPET parameters, peak V′O2 values had the best discriminative power to identify the high-risk group of patients. In agreement with previous reports, we confirmed that a peak V′O2 >20 mL·kg−1·min−1 is a safe cut-off value for lung resection since no mortality and <8% respiratory and cardiac complications occurred above this threshold 13, 23, 24, 25. In contrast, below 10 mL·kg−1·min−1peak V′O2, patients experienced a four-fold higher incidence of cardiovascular and pulmonary complications, compared with surgical candidates presenting peak V′O2 values >20 mL·kg−1·min−1. Nevertheless, the use of peak V′O2 expressed in mL·kg−1 may lead to exclusion of obese candidates who are actually fit enough to undergo surgery. As peak V′O2,max better correlates with lean body mass than total body weight, several physiologists have recommended the use of height and age in the calculation of predicted peak V′O2, particularly when candidates are overweight 22, 26.

Interestingly, in the multivariate analysis, ppo FEV1 based on the “segment method” failed to provide additional predictive value for cardiopulmonary complications. Actually, by adopting a functional algorithm for selecting surgical candidates, we excluded most patients with ppo FEV1 <30%. Moreover, in patients with chronic obstructive pulmonary disease (COPD), a “lung volume reduction” effect may take place after resection, providing minimal loss or even improvement in lung function 27, 28. Given the prognostic importance of ppo FEV1 regarding long-term quality of life, more accurate estimation of functional segments might have been achieved by using perfusion scintigraphy, quantitative CT or magnetic resonance imaging 29.

Although there is no firmly identified causal mechanism linking a low aerobic capacity with a high-risk profile, one explanation is that “unfit” patients are unable to face the increased surgical stress-induced metabolic demand by mounting an adequate increase in oxygen delivery 11. Pre-existing disturbances in cardiac pumping performances, respiratory function and oxygen utilisation within the skeletal muscles may worsen during the early post-operative period as a result of inadequate pain control, residual effects of anaesthesia, fluid overload, ventilator-induced lung injuries, direct surgical nerve damage, reflex inhibition of diaphragmatic function and muscular fatigue associated with systemic inflammation and enhanced protein catabolism. Indeed, patients with the lowest peak V′O2 values (<17 mL·kg−1·min−1) presented a higher index of comorbidity as reflected by ASA risk classes, a higher prevalence of arterial hypertensive disease and greater impairments in pulmonary function. Finally, oxidative stress has been shown to accelerate protein breakdown and to trigger nuclear apoptosis in unloaded skeletal muscle, thereby rendering these patients unable to sustain an adequate ventilatory response 30.

Previous investigators have limited their analysis mainly to pre-operative clinical and functional parameters that could affect the early post-operative outcome 13–15, 19, 25, 31. In the present study, we assessed >90 potential risk factors focusing on patient pre-operative condition but also on intra-operative markers of processes of care. In this regard, prolonged anaesthetic time probably reflected the dual aspects of a complex surgical approach as well as difficulties with anaesthesia emergence and weaning from the ventilator. Extended tissue dissection involving ischaemia-reperfusion injuries would obviously impose larger post-operative metabolic needs and greater loads on the cardiovascular and respiratory systems.

Not surprisingly, we found that age and performing a pneumonectomy or bilobectomy were additional risk factors for the occurrence of cardiac complications. Indeed, excess collagen deposition in the extracellular matrix coupled with a progressive loss of cardiac myocytes by apoptotic cell death are hallmarks of the senescent heart that have been incriminated in the pathogenesis of ventricular dysfunction and atrial fibrillation 32. Moreover, the pulmonary circulatory system becomes less compliant after extended parenchymal lung resection, resulting in increased right ventricular afterload 33. However, autonomic nerve injuries occur inevitably when surgical dissection involves the hilar mediastinal structures 34. Accordingly, the majority of cardiovascular complications consisting of arrhythmias (8%) and acute heart failure (3%) were probably related to age-associated myocardial remodelling, cardiac autonomic nerve imbalance and greater vulnerability to fluid loading.

Besides markers of cardiopulmonary fitness and the duration of anaesthesia, we found that the intra-operative ventilatory strategy significantly influenced the development of pneumonia, atelectasis and ALI, with larger VT being associated with higher operative risk. Consistent with this finding, VT >7–8 mL·kg−1 or elevated inspiratory pressure during one-lung ventilation have been associated with greater risks to develop ALI and with larger release of cytokines within the lungs and the systemic circulation 35, 36. Conversely, the application of “physiological” VT (4–7 mL·kg−1) and external PEEP in patients with healthy lungs undergoing oesophagectomy has been associated with an attenuated systemic pro-inflammatory response, lower interstitial pulmonary oedema and a better oxygenation index 37. Performing vital capacity manoeuvre has also been shown to re-expand the collapsed dependent lung areas that develop in almost all anaesthetised patients, whereas moderate levels of PEEP are known to prevent a subsequent fall in functional residual capacity by preventing cyclic opening–closing within pulmonary alveoli and peripheral airways 21, 38. Given the strong body of scientific knowledge related to perioperative ventilator-associated injuries, we have adopted a lung-protective protocol involving small VT, external PEEP and periodical recruitment manoeuvres since March 2003. Over the following 5-yr period, implementation of this “open-lung” strategy was associated with a reduced incidence of ALI and atelectasis, along with fewer admissions in intensive care 39.

There are some limitations and strengths of this observational study that should be mentioned. First, although >90 items were prospectively collected, we assume some variability in recorded data, unmeasured risk factors and diseases with low prevalence rate (e.g. diabetes mellitus and pulmonary hypertension) that could partly confound the interpretation of the multivariate analysis. Secondly, we obtained peak V′O2 data using bicycle exercise that might not be feasible in patients with lower extremities disabilities caused by vascular, neurological or orthopedic conditions. In such cases, arm exercise testing should be considered as a suitable alternative 40. Thirdly our findings obtained in a referral thoracic centre cannot be generalised to nonspecialised units in the absence of standardised clinical pathways. Implementation of bundles of scientifically-based interventions has been shown to improve perioperative outcome. If we compare the current data with those published previously 26, we have witnessed a 25% reduction in cardiopulmonary morbidity over the past 15 yrs; this is probably attributable to the beneficial effects of thoracic epidural analgesia, fluid titration guided by Doppler flow monitoring and protective lung ventilation 2, 39, 41.

Our selection criteria were less restrictive than in the initial algorithm since 29 patients with peak V′O2 <10 mL·kg−1·min−1 were considered suitable candidates for surgery, with 25 survivors, 14 of whom were without any serious complications. The majority of these very high-risk patients presented with early cancer stages IA and IB (55%) and moderate-to-severe COPD. Although no firm conclusions could be drawn from these encouraging data, some patients deemed inoperable (or at very high-risk) according to their very low peak V′O2 values might become eligible for curative surgery, particularly those with acceptable ppo FEV1/ppo DL,CO values (>30%). Moreover, data support that sublobar resection is a suitable alternative therapy for patients bearing a small sized tumour (<2–3 cm) whereas minimal deterioration of post-operative FEV1 has been observed in COPD patients after anatomical lobar resection as a result of a “volume reduction” effect 27, 28.

Finally, future trials should question whether improvement in aerobic performances induced by pre-operative physical training may reduce perioperative mortality and morbidity in these high-risk patients. To date, experimental data indicates that short-term intense physical training induces a cardioprotective phenotype similar to ischaemic preconditioning and enhances oxygen extraction from the skeletal muscle by increasing mitochondrial mass, capillary density and oxidative capacity 42, 43. Preliminary studies in elderly patients with cancer, arterial disease or heart failure confirm the beneficial physiological effects of a short-term supervised training programme, namely an increase in peak V′O2 (+20%) and in anaerobic threshold (10%), a reduction in plasma inflammatory markers and improvement in cardiac function 44–47.

In conclusion, our data strongly support the use of CPET for risk stratification in patients with pre-operative FEV1 <80%. Given substantial progress in surgical techniques and anaesthetic management over the last decades, even high-risk patients (peak V′O2 <10 mL·kg−1·min−1) may be considered for life-saving surgery. According to our results, several risk-reducing strategies can be implemented: 1) patient referral to a qualified and experienced thoracic team in order to shorten the time of intervention; 2) application of a protective ventilatory protocol to minimise pulmonary injuries triggered by mechanical ventilation; and 3) considering short-term pre-operative physical training in the “unfit” patients. Further studies are needed to replicate our observations and to question whether improved aerobic capacity achieved by exercise training is associated with better post-operative outcome in the high-risk group.

APPENDIX: MAJOR OUTCOMES

Mortality

Death within 30 days after surgery or for a longer period if the patient was still hospitalised

Cardiovascular

1) Myocardial infarction: typical rise and fall of creatine phophokinase (CPK) (>120 U·L−1) and MB isoform of creatine kinase/CPK ≥6% or troponin-I ≥1.5 ng·mL−1 with at least one of the following criteria: ischaemic symptoms, development of pathological Q waves on the ECG, ST segment elevation or depression (≥1 mm) or coronary artery intervention.

2) Arrhythmias: supraventricular and ventricular tachyarrhythmias on ECG causing unstable haemodynamic condition and requiring anti-arrhythmic medications and/or electrical cardioversion.

3) Congestive heart failure: need for sympathomimetic support, diuretics or vasodilators consistent with clinical, haemodynamic (pulmonary artery pressure ≥15 mmHg) and radiological evidence of pulmonary congestion.

4) Thrombo-embolism: acute occlusion of pulmonary arteries diagnosed by scintigraphy or angiogram.

5) Stroke: focal neurological deficit (transient or permanent).

6) Renal dysfunction: elevation of serum creatinine >50% compared with pre-operative value.

Respiratory

1) Atelectasis: lobar collapse (chest radiograph), need for continuous positive airway pressure and/or bronchoscopy.

2) Bronchopneumonia: temperature >38 °C, hyperleukocytosis (neutrophils), new lung infiltration (chest radiograph), positive culture (bronchial secretions or alveolar fluid)

3) Acute lung injury: 1) sudden onset of respiratory distress; 2) infiltrates on the chest radiograph consistent with pulmonary oedema; 3) impaired oxygenation with an arterial oxygen pressure-to-inspired oxygen fraction ratio <300 mmHg; and 4) absence of cardiac insufficiency or fluid overload, based on pulmonary arterial catheterisation, echocardiogram and/or clinical evaluation.

Footnotes

  • Statement of Interest

    None declared.

  • Received May 4, 2010.
  • Accepted August 30, 2010.
  • ©2011 ERS

REFERENCES

  1. ↵
    1. Boffa DJ,
    2. Allen MS,
    3. Grab JD,
    4. et al
    . Data from The Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors. J Thorac Cardiovasc Surg 2008; 135: 247–254.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Licker MJ,
    2. Widikker I,
    3. Robert J,
    4. et al
    . Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends. Ann Thorac Surg 2006; 81: 1830–1837.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Kates M,
    2. Perez X,
    3. Gribetz J,
    4. et al
    . Validation of a model to predict perioperative mortality from lung cancer resection in the elderly. Am J Respir Crit Care Med 2009; 179: 390–395.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Spiro SG,
    2. Tanner NT,
    3. Silvestri GA,
    4. et al
    . Lung cancer: progress in diagnosis, staging and therapy. Respirology;15: 44–50.
  5. ↵
    1. Colice GL,
    2. Shafazand S,
    3. Griffin JP,
    4. et al
    . Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd Edn). Chest 2007; 132 Suppl., 3161S–177S.
    OpenUrlCrossRefPubMedWeb of Science
    1. Bolliger CT,
    2. Koegelenberg CF,
    3. Kendal R
    . Preoperative assessment for lung cancer surgery. Curr Opin Pulm Med 2005; 11: 301–306.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. van Tilburg PMB,
    2. Stam H,
    3. Hoogsteden HC,
    4. et al
    . Pre-operative pulmonary evaluation of lung cancer patients: a review of the literature. Eur Respir J 2009; 33: 1206–1215.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Palange P,
    2. Ward SA,
    3. Carlsen K-H,
    4. et al
    . Recommendations on the use of exercise testing in clinical practice. Eur Respir J 2007; 29: 185–209.
    OpenUrlAbstract/FREE Full Text
    1. Jones LW,
    2. Eves ND,
    3. Haykowsky M,
    4. et al
    . Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations. Lancet Oncol 2008; 9: 757–765.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167: 211–277.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Albouaini K,
    2. Egred M,
    3. Alahmar A,
    4. et al
    . Cardiopulmonary exercise testing and its application. Heart 2007; 93: 1285–1292.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Brunelli A
    . Algorithm for functional evaluation of lung resection candidates: time for reappraisal? Respiration 2009; 78: 117–118.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Brunelli A,
    2. Belardinelli R,
    3. Refai M,
    4. et al
    . Peak oxygen consumption during cardiopulmonary exercise test improves risk stratification in candidates to major lung resection. Chest 2009; 135: 1260–1267.
    OpenUrlCrossRefPubMedWeb of Science
    1. Benzo R,
    2. Kelley GA,
    3. Recchi L,
    4. et al
    . Complications of lung resection and exercise capacity: a meta-analysis. Respir Med 2007; 101: 1790–1797.
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    1. Win T,
    2. Jackson A,
    3. Sharples L,
    4. et al
    . Cardiopulmonary exercise tests and lung cancer surgical outcome. Chest 2005; 127: 1159–1165.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Brunelli A,
    2. Charloux A,
    3. Bolliger CT,
    4. et al
    . ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J 2009; 34: 17–41.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Brunelli A,
    2. Charloux A,
    3. Bolliger CT,
    4. et al
    . The European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patients with lung cancer. Eur J Cardiothorac Surg 2009; 36: 181–184.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Wyser C,
    2. Stulz P,
    3. Soler M,
    4. et al
    . Prospective evaluation of an algorithm for the functional assessment of lung resection candidates. Am J Respir Crit Care Med 1999; 159: 1450–1456.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Bolliger CT,
    2. Jordan P,
    3. Soler M,
    4. et al
    . Exercise capacity as a predictor of postoperative complications in lung resection candidates. Am J Respir Crit Care Med 1995; 151: 1472–1480.
    OpenUrlPubMedWeb of Science
  17. ↵
    1. Tang SS,
    2. Redmond K,
    3. Griffiths M,
    4. et al
    . The mortality from acute respiratory distress syndrome after pulmonary resection is reducing: a 10-year single institutional experience. Eur J Cardiothorac Surg 2008; 34: 898–902.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Licker M,
    2. Fauconnet P,
    3. Villiger Y,
    4. et al
    . Acute lung injury and outcomes after thoracic surgery. Curr Opin Anaesthesiol 2009; 22: 61–67.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Hansen JE,
    2. Sue DY,
    3. Wasserman K
    . Predicted values for clinical exercise testing. Am Rev Respir Dis 1984; 129: S49–S55.
    OpenUrlPubMedWeb of Science
  20. ↵
    BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax 2001; 56: 89–108.
    OpenUrlFREE Full Text
  21. ↵
    1. Burke JR,
    2. Duarte IG,
    3. Thourani VH,
    4. et al
    . Preoperative risk assessment for marginal patients requiring pulmonary resection. Ann Thorac Surg 2003; 76: 1767–1773.
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    1. Brutsche MH,
    2. Spiliopoulos A,
    3. Bolliger CT,
    4. et al
    . Exercise capacity and extent of resection as predictors of surgical risk in lung cancer. Eur Respir J 2000; 15: 828–832.
    OpenUrlAbstract
  23. ↵
    1. Buskirk E,
    2. Taylor HL
    . Maximal oxygen intake and its relation to body composition, with special reference to chronic physical activity and obesity. J Appl Physiol 1957; 11: 72–78.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Brunelli A,
    2. Al Refai M,
    3. Monteverde M,
    4. et al
    . Predictors of early morbidity after major lung resection in patients with and without airflow limitation. Ann Thorac Surg 2002; 74: 999–1003.
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    1. Edwards JG,
    2. Duthie DJ,
    3. Waller DA
    . Lobar volume reduction surgery: a method of increasing the lung cancer resection rate in patients with emphysema. Thorax 2001; 56: 791–795.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Ohno Y,
    2. Koyama H,
    3. Nogami M,
    4. et al
    . Postoperative lung function in lung cancer patients: comparative analysis of predictive capability of MRI, CT, and SPECT. AJR Am J Roentgenol 2007; 189: 400–408.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    1. Chopard A,
    2. Hillock S,
    3. Jasmin BJ
    . Molecular events and signalling pathways involved in skeletal muscle disuse-induced atrophy and the impact of countermeasures. J Cell Mol Med 2009; 13: 3032–3050.
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    1. Bobbio A,
    2. Chetta A,
    3. Internullo E,
    4. et al
    . Exercise capacity assessment in patients undergoing lung resection. Eur J Cardiothorac Surg 2009; 35: 419–422.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    1. Chen W,
    2. Frangogiannis NG
    . The role of inflammatory and fibrogenic pathways in heart failure associated with aging. Heart Fail Rev 2010; 15: 415–422.
    OpenUrlCrossRefPubMedWeb of Science
  30. ↵
    1. Amar D,
    2. Burt ME,
    3. Roistacher N,
    4. et al
    . Value of perioperative Doppler echocardiography in patients undergoing major lung resection. Ann Thorac Surg 1996; 61: 516–520.
    OpenUrlCrossRefPubMedWeb of Science
  31. ↵
    1. Roselli EE,
    2. Murthy SC,
    3. Rice TW,
    4. et al
    . Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg 2005; 130: 438–444.
    OpenUrlPubMedWeb of Science
  32. ↵
    1. Licker M,
    2. de Perrot M,
    3. Spiliopoulos A,
    4. et al
    . Risk factors for acute lung injury after thoracic surgery for lung cancer. Anesth Analg 2003; 97: 1558–1565.
    OpenUrlCrossRefPubMedWeb of Science
  33. ↵
    1. Schilling T,
    2. Kozian A,
    3. Huth C,
    4. et al
    . The pulmonary immune effects of mechanical ventilation in patients undergoing thoracic surgery. Anesth Analg 2005; 101: 957–965.
    OpenUrlCrossRefPubMedWeb of Science
  34. ↵
    1. Michelet P,
    2. D'Journo XB,
    3. Roch A,
    4. et al
    . Protective ventilation influences systemic inflammation after esophagectomy: a randomized controlled study. Anesthesiology 2006; 105: 911–919.
    OpenUrlCrossRefPubMedWeb of Science
  35. ↵
    1. Wolthuis EK,
    2. Choi G,
    3. Dessing MC,
    4. et al
    . Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents pulmonary inflammation in patients without preexisting lung injury. Anesthesiology 2008; 108: 46–54.
    OpenUrlCrossRefPubMedWeb of Science
  36. ↵
    1. Licker M,
    2. Diaper J,
    3. Villiger Y,
    4. et al
    . Impact of intraoperative lung-protective interventions in patients undergoing lung cancer surgery. Crit Care 2009; 13: R41–
    OpenUrlCrossRefPubMed
  37. ↵
    1. Myers J,
    2. Arena R,
    3. Franklin B,
    4. et al
    . Recommendations for clinical exercise laboratories: a scientific statement from the American Heart Association. Circulation 2009; 119: 3144–3161.
    OpenUrlFREE Full Text
  38. ↵
    1. Diaper J,
    2. Ellenberger C,
    3. Villiger Y,
    4. et al
    . Transoesophageal Doppler monitoring for fluid and hemodynamic treatment during lung surgery. J Clin Monit Comput 2008; 22: 367–374.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Powers SK,
    2. Quindry JC,
    3. Kavazis AN
    . Exercise-induced cardioprotection against myocardial ischemia-reperfusion injury. Free Radic Biol Med 2008; 44: 193–201.
    OpenUrlCrossRefPubMedWeb of Science
  40. ↵
    1. Befroy DE,
    2. Petersen KF,
    3. Dufour S,
    4. et al
    . Increased substrate oxidation and mitochondrial uncoupling in skeletal muscle of endurance-trained individuals. Proc Natl Acad Sci USA 2008; 105: 16701–16706.
    OpenUrlAbstract/FREE Full Text
  41. ↵
    1. Bobbio A,
    2. Chetta A,
    3. Ampollini L,
    4. et al
    . Preoperative pulmonary rehabilitation in patients undergoing lung resection for non-small cell lung cancer. Eur J Cardiothorac Surg 2008; 33: 95–98.
    OpenUrlAbstract/FREE Full Text
    1. Kothmann E,
    2. Batterham AM,
    3. Owen SJ,
    4. et al
    . Effect of short-term exercise training on aerobic fitness in patients with abdominal aortic aneurysms: a pilot study. Br J Anaesth 2009; 103: 505–510.
    OpenUrlAbstract/FREE Full Text
    1. Wisloff U,
    2. Stoylen A,
    3. Loennechen JP,
    4. et al
    . Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 2007; 115: 3086–3094.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    1. Jones LW,
    2. Eves ND,
    3. Mackey JR,
    4. et al
    . Systemic inflammation, cardiorespiratory fitness, and quality of life in patients with advanced non-small cell lung cancer. J Thorac Oncol 2008; 3: 194–195.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 37 Issue 5 Table of Contents
European Respiratory Journal: 37 (5)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of aerobic exercise capacity and procedure-related factors in lung cancer surgery
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Impact of aerobic exercise capacity and procedure-related factors in lung cancer surgery
M. Licker, J-M. Schnyder, J-G. Frey, J. Diaper, V. Cartier, C. Inan, J. Robert, P-O. Bridevaux, J-M. Tschopp
European Respiratory Journal May 2011, 37 (5) 1189-1198; DOI: 10.1183/09031936.00069910

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Impact of aerobic exercise capacity and procedure-related factors in lung cancer surgery
M. Licker, J-M. Schnyder, J-G. Frey, J. Diaper, V. Cartier, C. Inan, J. Robert, P-O. Bridevaux, J-M. Tschopp
European Respiratory Journal May 2011, 37 (5) 1189-1198; DOI: 10.1183/09031936.00069910
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • MATERIAL AND METHODS
    • RESULTS
    • DISCUSSION
    • APPENDIX: MAJOR OUTCOMES
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Lung cancer
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original Article

  • Lung volumes and survival in chronic lung allograft dysfunction
  • Spirometer controlled cine-MRI and TBM in paediatric patients
  • Prior CV disease and mortality COPD pneumonia patients
Show more Original Article

Thoracic Oncology

  • Non-inferiority trials in advanced NSCLC
  • The lung cancer patient, the pneumologist and palliative care
  • thoracic oncology
Show more Thoracic Oncology

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society